SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

Added 406 days ago (27.10.2020)
Authors: Tuttle, K. R.; Brosius, F. C.; Cavender, M. A.; Fioretto, P.; Fowler, K. J.; Heerspink, H. J. L.; Manley, T.; McGuire, D. K.; Molitch, M. E.; Mottl, A. K.; Perreault, L.; Rosas, S. E.; Rossing, P.; Sola, L.; Vallon, V.; Wanner, C.; Perkovic, V.
Read article